Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug;100(8):1493-9.
doi: 10.2105/AJPH.2008.158949. Epub 2009 Nov 12.

Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005

Marsha Lillie-Blanton  1 , Valerie E Stone, Alison Snow Jones, Jeffrey Levi, Elizabeth T Golub, Mardge H Cohen, Nancy A Hessol, Tracey E Wilson
Affiliations

Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005

Marsha Lillie-Blanton et al. Am J Public Health. 2010 Aug.

Abstract

Objectives: We examined racial/ethnic disparities in highly active antiretroviral therapy (HAART) use and whether differences are moderated by substance use or insurance status, using data from the Women's Interagency HIV Study (WIHS).

Methods: Logistic regression examined HAART use in a longitudinal cohort of women for whom HAART was clinically indicated in 2005 (N = 1354).

Results: Approximately 3 of every 10 eligible women reported not taking HAART. African American and Hispanic women were less likely than were White women to use HAART. After we adjusted for potential confounders, the higher likelihood of not using HAART persisted for African American but not for Hispanic women. Uninsured and privately insured women, regardless of race/ethnicity, were less likely than were Medicaid enrollees to use HAART. Although alcohol use was related to HAART nonuse, illicit drug use was not.

Conclusions: These findings suggest that expanding and improving insurance coverage should increase access to antiretroviral therapy across racial/ethnic groups, but it is not likely to eliminate the disparity in use of HAART between African American and White women with HIV/AIDS.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Percentage of clinically eligible women not using highly active antiretroviral therapy (HAART), by race/ethnicity and insurance: Women's Interagency HIV Study, 2005.
FIGURE 2
FIGURE 2
Reasons cited for not taking highly active antiretroviral therapy (HAART): Women's Interagency HIV Study, 2005.
See this image and copyright information in PMC

References

    1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338(13):853–860 - PubMed
    1. Levine RS, Briggs NC, Kilbourne BS, et al. Black–White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996. Am J Public Health 2007;97(10):1884–1892 - PMC - PubMed
    1. Cohen MH, Cook JA, Grey DD, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health 2004;94(7):1147–1151 - PMC - PubMed
    1. Shapiro MF, Morton SC, McCaffrey D, et al. Variations in the care of HIV-infected adults in the United States. JAMA 1999;281(24):2305–2315 - PubMed
    1. Cunningham WE, Mardson LW, Andersen RM, et al. Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. J Acquir Immune Defic Syndr 2000;25(2):115–123 - PubMed

Publication types

MeSH terms